Logo
x

Search

Subscribe Now

 Pharma

Nippon Shinyaku Collaborates with Atsena Therapeutics to Commercialize ATSN-101 Across the US and Japan

Nippon Shinyaku Collaborates with Atsena Therapeutics to Commercialize ATSN-101 Across the US and Japan

  • November 13, 2024
Schrödinger Enters into a Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

Schrödinger Enters into a Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis

  • November 13, 2024
Apollo Therapeutics Joins Forces with Sunshine Lake Pharma to Develop APL-18881 for Multiple Indications

Apollo Therapeutics Joins Forces with Sunshine Lake Pharma to Develop APL-18881 for Multiple Indications

  • November 12, 2024
Alteogen and Daiichi Sankyo Partner to Develop and Commercialize SC Formulation of Enhertu

Alteogen and Daiichi Sankyo Partner to Develop and Commercialize SC Formulation of Enhertu

  • November 11, 2024
PharmaShots Weekly Snapshots (November 04 – November 08, 2024)

PharmaShots Weekly Snapshots (November 04 – November 08, 2024)

  • November 11, 2024
Inocras and Summit Pharmaceuticals International Corporation Join Forces to Advance Healthcare in Japan

Inocras and Summit Pharmaceuticals International Corporation Join Forces to Advance Healthcare in Japan

  • November 6, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.